SCHEMBL22452579

SCHEMBL22452579

COC(=O)c1cccnc1N(C)c1cccc(Nc2ccc(C34CC5CC(CC(C5)C3)C4)cc2Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.40
▸ HIF1A Q16665 9/20 0.39
▸ EPAS1 Q99814 3/20 0.39
▸ HTT P42858 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ MDH1 P40925 2/20 0.37
▸ MDH2 P40926 2/20 0.37
▸ SERPINE1 P05121 2/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ GPR55 Q9Y2T6 1/20 0.35
▸ DHODH Q02127 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ PKM P14618 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ EP300 Q09472 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22452747 0.92 SERPINE1 (0.41) HIF1AEPAS1HTTLMNAGAA
SCHEMBL22452574 0.92 CNR2 (0.41) CNR2HIF1AEPAS1LMNAMDH1
SCHEMBL22452580 0.86 CNR2 (0.52) CNR2HIF1AEPAS1HTTLMNA
SCHEMBL22452697 0.83 SERPINE1 (0.41) HIF1AEPAS1HTTLMNAGAA
SCHEMBL22452628 0.83 CNR2 (0.47) CNR2HIF1AEPAS1HTTLMNA
SCHEMBL22453117 0.82 CNR2 (0.53) CNR2HIF1AEPAS1HTTGAA
SCHEMBL22453494 0.81 CNR2 (0.56) CNR2HIF1AEPAS1LMNAMDH1
SCHEMBL22453152 0.80 CNR2 (0.47) CNR2HIF1AEPAS1HTTLMNA
SCHEMBL22452627 0.80 CNR2 (0.51) CNR2HIF1AEPAS1HTTLMNA
SCHEMBL22452973 0.79 CNR2 (0.40) CNR2HIF1AEPAS1LMNAMDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020190774-A1 NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS THE GENERAL HOSPITAL CORPORATION (US) 2020-09-24 — — WO disclosed
Send feedback